RNF39 Antikörper (C-Term)
Kurzübersicht für RNF39 Antikörper (C-Term) (ABIN629742)
Target
Alle RNF39 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- RNF39 antibody was raised against the C terminal of RNF39
-
Aufreinigung
- Purified
-
Immunogen
- RNF39 antibody was raised using the C terminal of RNF39 corresponding to a region with amino acids CRSINSNPHFRPKIMRPHLVSTFPRPCSKPNPFLPSGSQNLLSPTATTVL
-
-
-
-
Applikationshinweise
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
RNF39 Blocking Peptide, catalog no. 33R-1798, is also available for use as a blocking control in assays to test for specificity of this RNF39 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of RNF39 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- RNF39 (Ring Finger Protein 39 (RNF39))
-
Andere Bezeichnung
- RNF39
-
Hintergrund
- Its gene lies within the major histocompatibility complex class I region on chromosome 6. Studies of a similar rat protein suggest that RNF39 plays a role in an early phase of synaptic plasticity. Its gene lies within the major histocompatibility complex class I region on chromosome 6.
-
Molekulargewicht
- 28 kDa (MW of target protein)
Target
-